Beat Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 6

Beat Therapeutics General Information

Description

Developer of oncology therapeutics designed for the treatment of aggressive cancers with limited therapeutic options. The company's platform focuses on the discovery and development of small-molecule therapies targeting cancer cell DNA repair pathways, supporting preclinical research, therapeutic candidate evaluation, and drug development activities for breast, ovarian, pancreatic, and other hard-to-treat cancers, enabling the biopharmaceutical and oncology markets to advance potential treatment options for patients with treatment-resistant disease.

Contact Information

Website
www.beattherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rua Alfredo Allen 455/461
  • Porto, 4200-135
  • Portugal
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Rua Alfredo Allen 455/461
  • Porto, 4200-135
  • Portugal

Beat Therapeutics Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Beat Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Accelerator/Incubator 14-Apr-2025 Completed Generating Revenue
7. Early Stage VC 01-Apr-2024 Completed Generating Revenue
6. Grant 28-Jan-2024 Completed Generating Revenue
5. Grant 21-Nov-2023 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Beat Therapeutics’s complete valuation and funding history, request access »

Beat Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Beat Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Portugal Ventures Venture Capital Minority
ANJE Corporation
EIT Health Accelerator/Incubator
Ready2Scale Accelerator/Incubator
UPTEC Accelerator/Incubator
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Beat Therapeutics FAQs

  • When was Beat Therapeutics founded?

    Beat Therapeutics was founded in 2023.

  • Where is Beat Therapeutics headquartered?

    Beat Therapeutics is headquartered in Porto, Portugal.

  • What is the size of Beat Therapeutics?

    Beat Therapeutics has 7 total employees.

  • What industry is Beat Therapeutics in?

    Beat Therapeutics’s primary industry is Biotechnology.

  • Is Beat Therapeutics a private or public company?

    Beat Therapeutics is a Private company.

  • What is Beat Therapeutics’s current revenue?

    The current revenue for Beat Therapeutics is .

  • How much funding has Beat Therapeutics raised over time?

    Beat Therapeutics has raised $26.5K.

  • Who are Beat Therapeutics’s investors?

    Portugal Ventures, ANJE, EIT Health, Ready2Scale, and UPTEC are 5 of 6 investors who have invested in Beat Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process